|
2009 Announcements 24 Dec 2009
Change of Director's Interest Notice (Scott)
23 Dec 2009
Cleansing statement 23 Dec 2009
23 Dec 2009
Appendix 3B (options) 23 Dec 2009
23 Dec 2009
Neuren Completes Shareholder Approved Funding
23 Dec 2009
Appendix 3B (shares) 23 Dec 2009
22 Dec 2009
Results of SSM
15 Dec 2009
Initial Director's Interest Notice (Holaday)
4 Dec 2009
Notice of SSM Dec 2009
4 Dec 2009
Appendix 3B
4 Dec 2009
Cleansing statement 4 Dec 2009
25 Nov 2009
Dr John Holaday joins Neuren Board
18 Nov 2009
Neuren Arranges up to AU$7.8m in New Funding
17 Nov 2009
Appendix 3B Shares Nov 2009
17 Nov 2009
Appendix 3B Note Nov 2009
17 Nov 2009
Appendix 3B Options Nov 2009
25 Sep 2009
Appendix 3B Sept 2009
31 Aug 2009
Appendix 4D June 2009
31 Aug 2009
Neuren Interim Report 2009
14 Aug 2009
Neuren raises NZ$1 million through SPP
14 Aug 2009
Appendix 3B SPP Shares Aug 2009
31 Jul 2009
Appendix 4C June 2009
20 Jul 2009
Chairman's Letter re SPP
20 Jul 2009
SPP Offer Document July 2009
20 Jul 2009
NNZ-2566 Development Overview
15 Jul 2009
Share Purchase Plan terms amended
10 Jul 2009
Share Purchase plan announced July 2009
1 Jul 2009
Neuren obtains further US$14m US Army funding
28 May 2009
Chairman's address to 2009 AGM
28 May 2009
AGM presentation
30 Apr 2009
Appendix 4C Mar 2009
28 Apr 2009
Notice of Annual General Meeting/Proxy Form
22 Apr 2009
Neuren Progresses Cancer Program through Perseis Therapeutics
31 Mar 2009
Annual Report 2008
27 Feb 2009
Preliminary Final Results (App 4E) Dec 2008
30 Jan 2009
Appendix 4C Dec 2008
21 Jan 2009
Neuren Strategy Update Jan 2009
|
